Radionuclide-antibody conjugates for single-cell cytotoxicity

This publication has 18 references indexed in Scilit:

• High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate
  Nuclear Medicine and Biology, 2001
• Therapeutic efficacy and dose-limiting toxicity of auger-electronvs. beta emitters in radioimmunotherapy with internalizing antibodies: Evaluation of125I-vs.131I-labeled CO17-1A in a human colorectal cancer model
  International Journal of Cancer, 1998
• Preparation of 211At-Labeled Humanized Anti-Tac Using 211At Produced in Disposable Internal and External Bismuth Targets
  Nuclear Medicine and Biology, 1998
• Optimizations of Radiolabeling of Immunoproteins with ²¹³Bi
  Radiochimica Acta, 1997
• SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2
  International Journal of Cancer, 1994
• Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Radiation spectra for Auger‐electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6
  Medical Physics, 1992
• An improved generator for the production of 212Pb and 212Bi from 224Ra
  Applied Radiation and Isotopes, 1988
• Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.
  Proceedings of the National Academy of Sciences, 1986
• Electron Dosimetry for Radioimmunotherapy: Optimal Electron Energy
  Radiation Protection Dosimetry, 1985